The global BCG Vaccine Market, valued at USD 86.4 million in 2023, is projected to grow to USD 90.3 million in 2024 and reach USD 127.9 million by 2031. This growth reflects a compound annual growth rate (CAGR) of 5.11% during the forecast period. The increasing demand for effective tuberculosis prevention and the expanding applications of the BCG vaccine in cancer treatment are key factors...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek